Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong · Delayed Price · Currency is HKD 27.40
-1.44 (-4.99%)
Sep 11, 2026, 4:08 PM HKT
HKG:3378 Revenue
Hanx Biopharmaceuticals (Wuhan) had revenue of 3.00K CNY in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 73.00K. In the year 2025, Hanx Biopharmaceuticals (Wuhan) had annual revenue of 92.00K, down -95.82%.
Revenue (ttm)
73.00K CNY
Revenue Growth
-95.82%
P/S Ratio
44,287.77
Revenue / Employee
1.22K CNY
Employees
60
Market Cap
3.73B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 92.00K | -2.11M | -95.82% |
| Dec 31, 2024 | 2.20M | -340.00K | -13.39% |
| Dec 31, 2023 | 2.54M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.